Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2009 1
2010 1
2011 1
2012 1
2017 2
2018 3
2019 2
2020 7
2021 8
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Antibody drug conjugates: Progress, pitfalls, and promises.
Mukherjee A, Waters AK, Babic I, Nurmemmedov E, Glassy MC, Kesari S, Yenugonda VM. Mukherjee A, et al. Among authors: nurmemmedov e. Hum Antibodies. 2019;27(1):53-62. doi: 10.3233/HAB-180348. Hum Antibodies. 2019. PMID: 30223393 Review.
WNT Signaling as a Therapeutic Target for Glioblastoma.
Latour M, Her NG, Kesari S, Nurmemmedov E. Latour M, et al. Among authors: nurmemmedov e. Int J Mol Sci. 2021 Aug 5;22(16):8428. doi: 10.3390/ijms22168428. Int J Mol Sci. 2021. PMID: 34445128 Free PMC article. Review.
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.
Barreyro L, Sampson AM, Ishikawa C, Hueneman KM, Choi K, Pujato MA, Chutipongtanate S, Wyder M, Haffey WD, O'Brien E, Wunderlich M, Ramesh V, Kolb EM, Meydan C, Neelamraju Y, Bolanos LC, Christie S, Smith MA, Niederkorn M, Muto T, Kesari S, Garrett-Bakelman FE, Bartholdy B, Will B, Weirauch MT, Mulloy JC, Gul Z, Medlin S, Kovall RA, Melnick AM, Perentesis JP, Greis KD, Nurmemmedov E, Seibel WL, Starczynowski DT. Barreyro L, et al. Among authors: nurmemmedov e. Sci Transl Med. 2022 Mar 9;14(635):eabb7695. doi: 10.1126/scitranslmed.abb7695. Epub 2022 Mar 9. Sci Transl Med. 2022. PMID: 35263148
Pritumumab, the first therapeutic antibody for glioma patients.
Babic I, Nurmemmedov E, Yenugonda VM, Juarez T, Nomura N, Pingle SC, Glassy MC, Kesari S. Babic I, et al. Among authors: nurmemmedov e. Hum Antibodies. 2018 Feb 5;26(2):95-101. doi: 10.3233/HAB-170326. Hum Antibodies. 2018. PMID: 29036806 Review.
ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer.
McMellen A, Yamamoto TM, Qamar L, Sanders BE, Nguyen LL, Ortiz Chavez D, Bapat J, Berning A, Post MD, Johnson J, Behbakht K, Nurmemmedov E, Chuong EB, Bitler BG. McMellen A, et al. Among authors: nurmemmedov e. Mol Cancer Res. 2023 Jan 3;21(1):3-13. doi: 10.1158/1541-7786.MCR-22-0102. Mol Cancer Res. 2023. PMID: 36149636 Free PMC article.
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer.
Foote JB, Mattox TE, Keeton AB, Chen X, Smith FT, Berry KL, Holmes T, Wang J, Huang CH, Ward AB, Hardy C, Fleten KG, Flatmark K, Yoon KJ, Sarvesh S, Ganji PN, Maxuitenko Y, Valiyaveettil J, Carstens JL, Buchsbaum DJ, Yang J, Zhou G, Nurmemmedov E, Babic I, Gaponenko V, Abdelkarim H, Mitra AK, Boyd MR, Manne U, Bae S, El-Rayes BF, Piazza GA. Foote JB, et al. Among authors: nurmemmedov e. bioRxiv [Preprint]. 2024 Jan 24:2023.05.17.541233. doi: 10.1101/2023.05.17.541233. bioRxiv. 2024. PMID: 38328254 Free PMC article. Preprint.
Wnt pathway: a hallmark of drug discovery challenge.
Babic I, Yenugonda VM, Kesari S, Nurmemmedov E. Babic I, et al. Among authors: nurmemmedov e. Future Med Chem. 2018 Jun 1;10(12):1399-1403. doi: 10.4155/fmc-2018-0084. Epub 2018 May 21. Future Med Chem. 2018. PMID: 29779411 No abstract available.
Activation of Wnt signaling promotes olaparib resistant ovarian cancer.
Yamamoto TM, McMellen A, Watson ZL, Aguilera J, Ferguson R, Nurmemmedov E, Thakar T, Moldovan GL, Kim H, Cittelly DM, Joglar AM, Brennecke EP, Wilson H, Behbakht K, Sikora MJ, Bitler BG. Yamamoto TM, et al. Among authors: nurmemmedov e. Mol Carcinog. 2019 Oct;58(10):1770-1782. doi: 10.1002/mc.23064. Epub 2019 Jun 10. Mol Carcinog. 2019. PMID: 31219654 Free PMC article.
31 results